LUNG

Pulmonx Corp

1.65

0.04+2.48%

After Hours: 1.680 +0.030 +1.82%19:32 08/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.650/1.610

TODAY RANGE1.590-1.753

VOL1.67M

MARKET CAP67.23M

52 WEEK RANGE1.590-9.37

AVG VOL (3M)488.52K

% TURNOVER4.09%

TURNOVER--

P/E (TTM)-1.1540

% RANGE10.10%

EPS(TTM)-1.4298

P/E(FORWARD)-1.0645

P/B0.9614

BVPS1.716

DIVIDEND--

P/S0.7835

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP63.63M

SHARES OUTSTANDING40.75M

NEXT EARNINGS10/28-11/03

FREE FLOAT38.56M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·3d ago
Pulmonx Price Target Cut to $3.00/Share From $6.00 by Wells Fargo
Dow Jones·3d ago
Pulmonx Is Maintained at Equal-Weight by Wells Fargo
Benzinga·3d ago
Wells Fargo Maintains Equal-Weight on Pulmonx, Lowers Price Target to $3
TipRanks·3d ago
Wells Fargo Remains a Hold on Pulmonx (LUNG)
Reuters·3d ago
PULMONX CORP. <LUNG.O>: WELLS FARGO CUTS TARGET PRICE TO $3 FROM $6
Reuters·3d ago
U.S. RESEARCH ROUNDUP-Alnylam, Amazon, Appfolio
TipRanks·4d ago
Pulmonx Corporation’s Earnings Call: Mixed Sentiment Amid Growth
Dow Jones·4d ago
Pulmonx Price Target Cut to $8.00/Share From $12.00 by Lake Street
Dow Jones·4d ago
Pulmonx Is Maintained at Buy by Lake Street
Benzinga·4d ago
Lake Street Maintains Buy on Pulmonx, Lowers Price Target to $8
Seeking Alpha·4d ago
Pulmonx slumps as Piper Sandler downgrades despite Q2 beat
Benzinga·4d ago
Analyst Expectations For Pulmonx's Future
Benzinga·4d ago
Crude Oil Falls 1%; Meta Earnings Top Views
Benzinga·4d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·4d ago
Pulmonx Is Maintained at Buy by Stifel

Same Industry

Name/Symbol

Change%

Price

Pulmonx Corp

LUNG

+2.48%

1.65

Atrion Corp

ATRI

0.00%

459.92

IDEXX Laboratories

IDXX

+27.49%

682.78

Cencora Inc.

COR

+1.83%

293.64

Teleflex Inc

TFX

+0.15%

116.06

Stryker Corp

SYK

+0.98%

381.49

West Pharm Svcs

WST

-0.36%

238.39

Ufp Technologies

UFPT

-0.13%

226.27

Shockwave Medical, Inc.

SWAV

0.00%

334.75

Cooper

COO

+0.82%

71.45

Becton Dickinson And Co

BDXB

48.16

Becton Dickinson & Co

BDX

+1.43%

178.90

Utah Med Prods

UTMD

+3.33%

56.78

Align Technology Inc

ALGN

+0.92%

137.77

Henry Schein

HSIC

+3.00%

70.02

Repligen

RGEN

-2.03%

116.50

Ge Healthcare Technologies Inc

GEHC

+1.13%

70.64

Abbott Labs

ABT

+2.07%

129.93

Conmed Corp

CNMD

+2.28%

53.48

Medtronic

MDT

+0.34%

89.64

Zimmer Biomet

ZBH

+1.96%

92.40

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English